Abstract
Twenty-seven patients with adenocarcinoma of the prostate, and available partners, were interviewed to qualitatively and quantitatively assess their level of sexual function prior to and 12 months after radiotherapy. Assessments were made using the Derogatis Interview for Sexual Functioning (DISF). Five domains of sexual functioning are measured: sexual fantasy, arousal, experience, orgasm, and drive. Prior to therapy 17 of 27 patients (62.9%) were considered impotent. There were eight patients with a DISF score of less than 20 who were impotent. Six patients had a DISF score of greater than 47 and were considered potent. Of the patients with DISF scores between 20-47 four were potent, and nine were impotent. Post radiation therapy three of the patients considered potent (with a score greater than 47) maintained their potent status. Four patients considered impotent prior to therapy became potent after therapy. All patients with a score less than 20 prior to radiation therapy remained impotent after therapy. Results indicate that an objective evaluation of sexual function pre treatment is necessary to determine the effect of radiotherapy. Our method of qualitative assessment of sexual function was easy to implement, was reproducible and could be used to evaluate long-term effects of radiotherapy on sexual function. Of the patients presenting for radiotherapy, 62.9% were impotent. Twelve months after radiation therapy 19 of 27 (70.3%) were impotent.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 729-732 |
| Number of pages | 4 |
| Journal | International Journal of Radiation Oncology, Biology, Physics |
| Volume | 19 |
| Issue number | 3 |
| DOIs | |
| State | Published - 1990 |
Fingerprint
Keywords
- External beam irradiation
- Pre and posttreatment potency
- Prostate cancer
ASJC Scopus subject areas
- Oncology
- Radiology Nuclear Medicine and imaging
- Radiation
Cite this
Pre and posttreatment evaluation of sexual function in patients with adenocarcinoma of the prostate. / Zinreich, Eva S.; Derogatis, Leonard; Herpst, Jeffrey; Auvil, Georgiana; Piantadosi, Steven; Order, Stanley E.
In: International Journal of Radiation Oncology, Biology, Physics, Vol. 19, No. 3, 1990, p. 729-732.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Pre and posttreatment evaluation of sexual function in patients with adenocarcinoma of the prostate
AU - Zinreich, Eva S.
AU - Derogatis, Leonard
AU - Herpst, Jeffrey
AU - Auvil, Georgiana
AU - Piantadosi, Steven
AU - Order, Stanley E.
PY - 1990
Y1 - 1990
N2 - Twenty-seven patients with adenocarcinoma of the prostate, and available partners, were interviewed to qualitatively and quantitatively assess their level of sexual function prior to and 12 months after radiotherapy. Assessments were made using the Derogatis Interview for Sexual Functioning (DISF). Five domains of sexual functioning are measured: sexual fantasy, arousal, experience, orgasm, and drive. Prior to therapy 17 of 27 patients (62.9%) were considered impotent. There were eight patients with a DISF score of less than 20 who were impotent. Six patients had a DISF score of greater than 47 and were considered potent. Of the patients with DISF scores between 20-47 four were potent, and nine were impotent. Post radiation therapy three of the patients considered potent (with a score greater than 47) maintained their potent status. Four patients considered impotent prior to therapy became potent after therapy. All patients with a score less than 20 prior to radiation therapy remained impotent after therapy. Results indicate that an objective evaluation of sexual function pre treatment is necessary to determine the effect of radiotherapy. Our method of qualitative assessment of sexual function was easy to implement, was reproducible and could be used to evaluate long-term effects of radiotherapy on sexual function. Of the patients presenting for radiotherapy, 62.9% were impotent. Twelve months after radiation therapy 19 of 27 (70.3%) were impotent.
AB - Twenty-seven patients with adenocarcinoma of the prostate, and available partners, were interviewed to qualitatively and quantitatively assess their level of sexual function prior to and 12 months after radiotherapy. Assessments were made using the Derogatis Interview for Sexual Functioning (DISF). Five domains of sexual functioning are measured: sexual fantasy, arousal, experience, orgasm, and drive. Prior to therapy 17 of 27 patients (62.9%) were considered impotent. There were eight patients with a DISF score of less than 20 who were impotent. Six patients had a DISF score of greater than 47 and were considered potent. Of the patients with DISF scores between 20-47 four were potent, and nine were impotent. Post radiation therapy three of the patients considered potent (with a score greater than 47) maintained their potent status. Four patients considered impotent prior to therapy became potent after therapy. All patients with a score less than 20 prior to radiation therapy remained impotent after therapy. Results indicate that an objective evaluation of sexual function pre treatment is necessary to determine the effect of radiotherapy. Our method of qualitative assessment of sexual function was easy to implement, was reproducible and could be used to evaluate long-term effects of radiotherapy on sexual function. Of the patients presenting for radiotherapy, 62.9% were impotent. Twelve months after radiation therapy 19 of 27 (70.3%) were impotent.
KW - External beam irradiation
KW - Pre and posttreatment potency
KW - Prostate cancer
UR - http://www.scopus.com/inward/record.url?scp=0024997779&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024997779&partnerID=8YFLogxK
U2 - 10.1016/0360-3016(90)90503-C
DO - 10.1016/0360-3016(90)90503-C
M3 - Article
C2 - 2211222
AN - SCOPUS:0024997779
VL - 19
SP - 729
EP - 732
JO - International Journal of Radiation Oncology Biology Physics
JF - International Journal of Radiation Oncology Biology Physics
SN - 0360-3016
IS - 3
ER -